[CRVS] QoQ Quarter Result on 30-Sep-2017 [#Q3]

Stock
[CRVS] Corvus Pharmaceuticals, Inc.
Announcement Date
02-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- 15.11%
YoY- -23.50%
Quarter Report
CRVS's Result
CRVS's Financial Summary
View:
Show?
Quarter Result
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -11,631 -14,301 -11,929 -12,717 -14,981 -16,036 -11,086 3.26%
Tax 0 0 -219 0 0 0 -184 -
NP -11,631 -14,301 -11,929 -12,717 -14,981 -16,036 -11,086 3.26%
Tax Rate - - - - - - - -
Total Cost 11,631 14,301 11,929 12,717 14,981 16,036 11,086 3.26%
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
EPS -0.40 -0.63 -0.58 -0.62 -0.73 -0.79 -0.55 -19.17%
EPS Diluted -0.40 -0.63 -0.58 -0.62 -0.73 -0.79 -0.55 -19.17%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.